OmniVis logo β€” Rapid food borne pathogen detection technology 🦠 
Experienc...

OmniVis

Rapid food borne pathogen detection technology 🦠 Experience the power of the lab in the palm of your hand πŸ”¬

Founded 2017 United States South San Francisco, United States 6 employees Seed Total: $2.28M Biotechnology, Food and Beverage +3

General Information

Company Name OmniVis
Founded Year 2017
Location United States South San Francisco, United States
Employees 6
Industries Biotechnology, Food and Beverage, Health Care +2
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with OmniVis. To contact OmniVis, visit omnivistech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OmniVis compare?

A PDF of OmniVis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OmniVis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OmniVis

OmniVis, founded in 2017, is reshaping the landscape of food safety with its pioneering handheld device technology for the rapid detection of foodborne pathogens. Positioned at the intersection of Biotechnology, Food and Beverage, Health Care, Information Technology, and AgriTech, this United States-based startup is dedicated to advancing global food safety standards.

OmniVis' mission focuses on empowering food processing facilities with intuitive, reliable diagnostic tools that seamlessly integrate into existing safety protocols. By enabling immediate and accurate detection of pathogens, OmniVis not only prevents potential contamination but also promotes consumer trust and well-being through transparency and innovation.

The company secured a $100.00K Pre Seed Round investment on April 24, 2023, with funding from HudsonAlpha AgTech. With these resources, OmniVis aims to drive its mission forward, ensuring food safety stays a priority from farm to fork.

Business keywords: food safety, pathogen detection, rapid diagnostics, handheld devices, innovation, technology, consumer well-being, lab testing, ultrasensitive device, disease detection, E. coli, global impact

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $100.00K 1
Purdue Ag-celerator
01 Feb 2023
Grant $150.00K 1
National Science Foundation
01 Aug 2022
Seed $280.00K 3
Ali Capital, Propel Bio Partners +1
01 May 2021
Grant $400.00K 1
National Institute of Standards and Technology (NIST)
01 Aug 2020
Grant $790.00K 1
National Science Foundation
01 Apr 2020
Spinout Undisclosed 1
Purdue University
01 Jan 2020
Grant $100.00K 1
National Institute of Standards and Technology (NIST)
01 Sep 2019
Grant $180.00K 1
Grand Challenges Canada
01 Feb 2019
Grant $50.00K 1
Elevate Ventures
01 Oct 2018
Grant $230.00K 1
National Science Foundation
01 Jun 2018

OmniVis Alternatives & Competitors

View All Alternatives
OmniVis vs
ProteoSense
ProteoSense United States

Making sure your food is safe and disrupting the food testing market with our rapid diagnostic platf...

Venture round
3 employees
Health Care, Information Technology
OmniVis vs

Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food saf...

Series C
6 employees
Biotechnology, Health Care
OmniVis vs
Biomode SA
Biomode SA Portugal

Biomode | Lighting up pathogen detection πŸ’‘ Biomode is an innovative company in the field of rapid...

Grant
1 employees
Biotechnology, Health Care

FAQ About OmniVis

Rapid food borne pathogen detection technology 🦠 Experience the power of the lab in the palm of your hand πŸ”¬
OmniVis was founded in 2017.
OmniVis is headquartered in South San Francisco, United States.
OmniVis operates in Biotechnology, Food and Beverage, Health Care, Information Technology and AgriTech. Its work centres on food safety, pathogen detection, rapid diagnostics and handheld devices.
OmniVis has approximately 6 employees.
OmniVis has completed 10 funding rounds, raising a total of $2.28M. The latest funding stage is Seed.
Top alternatives and competitors to OmniVis include ProteoSense, Pathogenetix, Inc., Biomode SA, T2 Biosystems, Sherlock Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OmniVis and ProteoSense are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OmniVis, https://bouncewatch.com/company/omnivis, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes